retatrutide clinical data FDA Approval Status 2026: Everything We Know So Far Retatrutide clinical trial done! Now – Perceived benefits of treatment for

But there are some differences from real-world-evidence: Patients were treatment-naive, with diabetes for only about 2.5 years on average

Mansour MR, Hannawa OM, Yaldo MM, Nageeb EM, Chaiyasate K

In fact, a recent study found that semaglutide was more effective than liraglutide for losing weight in obese adults, even under a different placebo group

However, researchers discovered something crucial: at the doses used in retatrutide, the GLP-1 and GIP components effectively manage glucose levels

What may be surprising is that metabolic disorders like obesity are actually a relatively minor area of research for cyclic peptides